Predictors of viability in patients with negative low-dose dobutamine stress echocardiography

Arquivos Brasileiros de Cardiologia

Volumn 96, Issue 3, 2011, Pages 188-194

  Abdel Salam, Zainab ^a   Nammas, Wail ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Dobutamine stress echocardiography; Predictors; Revascularization; Viability

Indexed keywords

DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MOVEMENT; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE WALL MOTION; HUMAN; LOW DRUG DOSE; MALE; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY;

DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY, STRESS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL CONTRACTION; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RECOVERY OF FUNCTION; RISK FACTORS; ROC CURVE; TECHNETIUM TC 99M SESTAMIBI;

EID: 79955544869     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2011005000007     Document Type: Article

References (28)

1. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation. 1993;87(1):1-20.
2. Hoffmann R. Stress echocardiography before and after interventional therapy. In: Marwick TH (ed.) Cardiac stress testing and imaging: a clinician's guide. New York: Churchill Livingston; 1996. p. 355-367.
3. Beller GA. Comparison of 201Tl scintigraphy and low-dose dobutamine echocardiography for the noninvasive assessment of myocardial viability. Circulation. 1996;94(11):2712-2719.
4. Jiménez Borreguero LJ, Ruiz-Salmerón R. Assessment of myocardial viability in patients before revascularization. Rev Esp Cardiol. 2003;56(7):721-733.
5. Marwick TH. Stress echocardiography. Heart. 2003;89(1):113-118.
6. Grayburn PA. Defining the threshold of myocardial viability by dobutamine echocardiography. Int J Cardiol. 2003;90(1):31-32.
7. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by twodimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2(5):358-367.
8. Knudsen AS, Darwish AZ, Nørgaard A, Gøtzsche O, Thygesen K. Time course of myocardial viability after acute myocardial infarction: an echocardiographic study. Am Heart J. 1998;135(1):51-57.
9. Chaudhry FA, Singh B, Galatro K. Reversible left ventricular dysfunction. Echocardiography. 2000;17(5):495-506.
10. Meluzín J, Cerný J, Frélich M, Stetka F, Spinarová L, Popelová J, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol. 1998;32(4):912-920.
11. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105(4):539-542.
12. Hendel RC, Chaudhry FA, Bonow RO. Myocardial viability. Curr Probl Cardiol. 1996;21(3):145-221.
13. Bonow RO. Contractile reserve and coronary blood flow reserve in collateraldependent myocardium. J Am Coll Cardiol. 1999;33(3):705-707.
14. Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol. 2007;32(7):375-410.
15. Vanoverschelde JL, Wijns W, Borgers M, Heyndrickx G, Depré C, Flameng W, et al. Chronic myocardial hibernation in humans. From bedside to bench. Circulation. 1997;95(7):1961-1971.
16. Ausma J, Cleutjens J, Thoné F, Flameng W, Ramaekers F, Borgers M. Chronic hibernating myocardium: interstitial changes. Mol Cell Biochem. 1995;147(1-2):35-42.
17. Valen G. The basic biology of apoptosis and its implications for cardiac function and viability. Ann Thorac Surg. 2003;75(2):S656-S660.
18. Saffitz JE, Yamada KA. Do alterations in intercellular coupling play a role in cardiac contractile dysfunction? Circulation. 1998;97(7):630-632.
19. Elsässer A, Müller KD, Skwara W, Bode C, Kübler W, Vogt AM. Severe energy deprivation of human hibernating myocardium as possible common pathomechanism of contractile dysfunction, structural degeneration and cell death. J Am Coll Cardiol. 2002;39(7):1189-1198.
20. Heusch G, Rose J, Skyschally A, Post H, Schulz R. Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart. Inotropic responses to postextrasystolic potentiation and intracoronary calcium. Circulation. 1996;93(8):1556-1566.
21. Kumbasar D, Akyürek O, Dincer I, Atmaca Y, Kiliçkap M, Erol C, et al. Good collaterals predict viable myocardium. Angiology. 2007;58(5):550-555.
22. Abdel-Salam Z, Nammas W. Predictors of myocardial contractile recovery after coronary revascularization in patients with prior myocardial infarction. Cardiovasc Revasc Med. 2010;11(1):2-7.
23. Balcells E, Powers ER, Lepper W, Belcik T, Wei K, Ragosta M, et al. Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting function and contractile reserve. J Am Coll Cardiol. 2003;41(5):827-833.
24. Kauffman GJ, Boyne TS, Watson DD, Smith WH, Beller GA. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol. 1996;27(7):1592-1597.
25. Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharach SL, et al. Myocardial viability in patients with chronic coronary artery disease: comparison of 99mTc-sestamibi with thallium reinjection and (18F) fluorodeoxyglucose. Circulation. 1994;89(2):578-587.
26. Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation. 1994;89(6):2552-2561.
27. Ciavolella M, Greco C, Tavolaro R, Tanzilli G, Scopinaro F, Campa PP. Acute oral trimetazidine administration increases resting technetium 99m sestamibi uptake in hibernating myocardium. J Nucl Cardiol. 1998;5(2):128-133.
28. Auerbach MA, Schöder H, Hoh C, Gambhir SS, Yaghoubi S, Sayre JW, et al. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation. 1999;99(22):2921-2926.